Twenty-Two Months: The Suicide Clause Meets Incontestability
Priya Nair's $500,000 whole life policy was issued on March 3, 2023, with an annual premium of $4,100 and her adult son Dev as beneficiary. The application asked whether she had been treated for depression or anxiety or taken prescription medication in the past five years; she answered no. After her death by suicide on January 14, 2025, the insurer obtained records showing she had been prescribed sertraline for 14 months before she applied, with a diagnosis of major depressive disorder. The policy contains a standard two-year suicide clause providing for return of premiums paid. The state's incontestability statute bars contesting a policy after it has been in force for two years from issue. No premiums were late, and the policy has not been reinstated. Dev has demanded the full $500,000 within 30 days and has threatened to file a complaint with the state insurance department.
1. At the time of death, which policy provision governs, and what should the insurer pay?
Read the worked answer
At death the policy had been in force for roughly 22 months, so both the suicide clause and the contestability period are open. Two provisions therefore apply to the same facts, and the insurer must choose. The suicide clause is the specific provision: it caps the payout at premiums paid, roughly $8,200 for two annual premiums. Rescinding for material misrepresentation is also available before the two-year mark, but rescission would produce essentially the same premium refund while requiring the insurer to prove materiality - that it would have declined or rated the policy had it known about the diagnosis and the medication. That is a litigable question, and litigating it buys a refund the insurer already owes.
The practical answer is to pay under the suicide clause, not rescind. The claim decision should cite the specific clause and the elapsed time, state the premium refund amount, and explain that the misrepresentation issue does not change the outcome. The file should record the records review and the reasoning. Accusatory language toward the beneficiary invites a bad-faith claim when the same money is owed either way.
2. How would the analysis change if Priya had died in April 2025 instead?
Read the worked answer
The outcome reverses. A death after March 3, 2025 falls outside both the two-year suicide clause and the two-year contestability period. The suicide exclusion no longer applies, so the manner of death is irrelevant to coverage. Incontestability bars the insurer from rescinding for the false answer about depression treatment, even though the misstatement is documented and arguably material.
The full $500,000 face amount is payable, and the insurer should pay it without a prolonged investigation. The only exceptions would be a state statute permitting contest for fraud beyond the incontestability period, or a separate provision that survived, and neither is standard. This is the entire purpose of incontestability: after two years, the insurer bears the underwriting risk it accepted. A claims examiner who discovers the medical records and denies anyway has confused a valid underwriting concern with a valid coverage defense, and the denial would likely be overturned with interest and a market-conduct finding.
3. Suppose the policy had lapsed in 2024 and been reinstated after a new application. How does that affect the two periods?
Read the worked answer
Reinstatement restarts the clock, but usually only partly. Most policies and state rules provide that the suicide clause and the contestability period run anew from the reinstatement date as to statements made in the reinstatement application. So if Priya had lapsed, reinstated in mid-2024, and died in January 2025, the suicide clause would again be within its two-year window and would limit the payout to premiums.
The contestability analysis splits. Misstatements in the reinstatement application would be contestable, but misstatements in the original 2023 application generally become incontestable two years after original issue and are not revived by reinstatement. So the insurer could not reach back to the original depression answer; it could only rely on what was asked and answered at reinstatement. Whether the reinstatement application repeated the medication question determines whether the insurer has any misrepresentation defense at all. Examiners should check the reinstatement application separately, and confirm the state's rule, because reinstatement contestability varies.